Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Observational Study
. 2018 Oct;14(25):2627-2642.
doi: 10.2217/fon-2018-0267. Epub 2018 Jun 18.

Economic burden of patients with diffuse large B-cell and follicular lymphoma treated in the USA

Vicki A Morrison  1 , Jill A Bell  2 , Laurie Hamilton  3 , Augustina Ogbonnaya  3 , Huai-Che Shih  3 , Kristin Hennenfent  3 , Michael Eaddy  3 , Yaping Shou  2 , Aaron Galaznik  2
Affiliations
Observational Study

Economic burden of patients with diffuse large B-cell and follicular lymphoma treated in the USA

Vicki A Morrison et al. Future Oncol. 2018 Oct.

Abstract

Aim: Evaluate healthcare costs and utilization of treated diffuse large B-cell lymphoma (DLBCL) and follicular lymphoma (FL) patients.

Materials & methods: Adults with newly diagnosed DLBCL and FL between 1 January 2008 and 31 October 2015 were identified in the Optum™ claims database. Healthcare costs and utilization were assessed from diagnosis date until end of follow-up.

Results: A total of 1267 DLBCL- and 1595 FL-treated patients were identified. Mean per-patient, per-month cost during follow-up was US$11,890 for DLBCL and US$10,460 for FL. Healthcare costs and utilization decreased from year 1 to 2 following diagnosis, due to a decrease in chemotherapy services, inpatient admissions and other outpatient services.

Conclusion: The economic burden of treated DLBCL and FL is considerable, especially in the first year following diagnosis.

Keywords: cost; diffuse large B-cell lymphoma; economic burden; follicular lymphoma; healthcare utilization; real-world; retrospective; treatment.

PubMed Disclaimer

Publication types